Target Product Profiles: Physician Insights on Key Attributes: Chronic Obstructive Pulmonary Disease

Table of Contents

• Introduction
  • Using Target Product Profi les in Your Market Strategy
  • Report Contents
  • Target Product Profi le Methodology
• Etiology and Pathophysiology
  • Overview
  • Anatomy
  • Disease Defi nition
    • Current Guidelines
    • Spirometric Measurement and Disease Severity
    • Causes of Airfl ow Limitation
    • Differentiating COPD and Asthma
  • Etiology
    • Exposure to Noxious Particles
    • Impaired Lung Development
    • Genetic Factors
    • Other Risk Factors
  • Pathophysiology
    • Role of Infl ammatory Cells
    • Receptors and Proteins Implicated in Infl ammation
    • Protease-Antiprotease Imbalance
    • Oxidative Stress
    • Direct Airway Damage
    • COPD Progression
• Target Product Profi le Discussion-Chronic Obstructive Pulmonary Disease
  • Target Product Profi le Summary for Chronic Obstructive Pulmonary Disease-2011
  • Assessing Drug Development Opportunities
  • Physician Survey Results
    • Effi cacy
    • Safety and Tolerability
    • Delivery
    • Estimated Patient Share
  • Pricing Potential
  • Forecasted 2016 Pricing Environment
  • Competitors to Watch
  • Emerging Product Profi le